Melissa Ducote
Family · Hessmer, LANPI 1679889349
Payments from drug & device makers
Across 111 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$328
- Novo Nordisk$261
- Takeda Pharmaceuticals U.S.A., Inc.$189
- Amgen$183
- Lilly USA, LLC$159
- GSK$139
- plus $645 from 15 others
What the payments were for
- Food & beverage$1,904100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $328 |
| Novo Nordisk | 19 | $261 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $189 |
| Amgen | 12 | $183 |
| Lilly USA, LLC | 9 | $159 |
| GSK | 9 | $139 |
| Boston Scientific | 1 | $100 |
| Pfizer | 6 | $96 |
| Merck | 6 | $83 |
| AstraZeneca | 5 | $81 |
| Johnson & Johnson | 3 | $44 |
| Novartis | 2 | $43 |
| Boehringer Ingelheim | 2 | $34 |
| Sunovion Pharmaceuticals Inc. | 2 | $31 |
| Abbott | 2 | $29 |
| Eagle Pharmaceuticals, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Exact Sciences | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,904 in reported general payments places this provider in the 75th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 94 | $75,577 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $33,156 |
| FarxigaDapagliflozin Propanediol | 25 | $27,482 |
| OzempicSemaglutide | 19 | $26,099 |
| Tresiba Flextouch U-200Insulin Degludec | 19 | $23,534 |
| TradjentaLinagliptin | 12 | $16,918 |
| XareltoRivaroxaban | 14 | $8,446 |
| EliquisApixaban | 11 | $7,616 |
| JanuviaSitagliptin Phosphate | 12 | $6,722 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 46 | $6,406 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 11 | $3,212 |
| Rosuvastatin Calcium | 113 | $2,771 |
| Nebivolol Hcl | 13 | $1,303 |
| Diclofenac Sodium | 41 | $1,267 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 51 | $1,151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $34 | $92,495106 claims |
| GSKTrelegy Ellipta, Arexvy | $139 | $36,36846 claims |
| AstraZenecaFarxiga | $81 | $27,48225 claims |
| Novo NordiskOzempic | $261 | $26,09919 claims |
| Johnson & JohnsonXarelto | $44 | $8,44614 claims |
| PfizerEliquis | $96 | $7,61611 claims |
| MerckJanuvia | $83 | $6,72212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,610 family providers in Louisiana.
Other family in Hessmer
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.